FI952629A - Kefiksiimivalmiste - Google Patents

Kefiksiimivalmiste Download PDF

Info

Publication number
FI952629A
FI952629A FI952629A FI952629A FI952629A FI 952629 A FI952629 A FI 952629A FI 952629 A FI952629 A FI 952629A FI 952629 A FI952629 A FI 952629A FI 952629 A FI952629 A FI 952629A
Authority
FI
Finland
Prior art keywords
micron
max
particles
suspensions
diameter
Prior art date
Application number
FI952629A
Other languages
English (en)
Swedish (sv)
Other versions
FI952629A0 (fi
Inventor
Joachim Bolz
Gertraud Wagner
Eckhard Oelrich
Dirk Radtke
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of FI952629A0 publication Critical patent/FI952629A0/fi
Publication of FI952629A publication Critical patent/FI952629A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI952629A 1994-05-31 1995-05-30 Kefiksiimivalmiste FI952629A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4418957A DE4418957A1 (de) 1994-05-31 1994-05-31 Cefixim-Zubereitung

Publications (2)

Publication Number Publication Date
FI952629A0 FI952629A0 (fi) 1995-05-30
FI952629A true FI952629A (fi) 1995-12-01

Family

ID=6519407

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952629A FI952629A (fi) 1994-05-31 1995-05-30 Kefiksiimivalmiste

Country Status (25)

Country Link
US (1) US5776926A (fi)
EP (1) EP0685232B1 (fi)
JP (1) JPH07330607A (fi)
KR (1) KR950031077A (fi)
CN (1) CN1117383A (fi)
AT (1) ATE190844T1 (fi)
AU (1) AU694201B2 (fi)
CA (1) CA2150442A1 (fi)
CO (1) CO4410174A1 (fi)
CZ (1) CZ138595A3 (fi)
DE (2) DE4418957A1 (fi)
DK (1) DK0685232T3 (fi)
ES (1) ES2146265T3 (fi)
FI (1) FI952629A (fi)
GR (1) GR3033704T3 (fi)
HU (1) HU218217B (fi)
IL (1) IL113917A0 (fi)
NO (1) NO952138L (fi)
NZ (1) NZ272216A (fi)
PE (1) PE18796A1 (fi)
PL (1) PL308838A1 (fi)
PT (1) PT685232E (fi)
SK (1) SK72795A3 (fi)
TW (1) TW301610B (fi)
ZA (1) ZA954427B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT890359E (pt) * 1996-02-29 2003-03-31 Fujisawa Pharmaceutical Co Comprimidos que contem antibiotico de beta-lactama e processo para a sua preparacao
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
JP2007536378A (ja) * 2004-05-10 2007-12-13 ルピン・リミテッド 生体利用性が強化されている新規セフィキシム医薬製剤
US9233112B2 (en) 2006-04-13 2016-01-12 Lupin Limited Pharmaceutical compositions of cefixime
DE112007000920T5 (de) 2006-04-13 2009-02-12 Lupin Ltd., Mumbai Pharmazeutische Zusammensetzungen von Cefixim
CN103301068B (zh) * 2013-07-08 2014-09-10 广东彼迪药业有限公司 一种头孢克肟干混悬剂剂及其制备方法
JP6449873B2 (ja) * 2013-07-18 2019-01-09 サンド・アクチエンゲゼルシヤフト 抗生物質のドライシロップ製剤用の粉末混合物
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11173163B2 (en) * 2015-08-05 2021-11-16 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins

Also Published As

Publication number Publication date
FI952629A0 (fi) 1995-05-30
IL113917A0 (en) 1995-08-31
AU2033595A (en) 1995-12-07
ATE190844T1 (de) 2000-04-15
HU9501570D0 (en) 1995-07-28
ZA954427B (en) 1996-01-24
NO952138D0 (no) 1995-05-30
DE4418957A1 (de) 1995-12-07
KR950031077A (ko) 1995-12-18
CA2150442A1 (en) 1995-12-01
SK72795A3 (en) 1996-01-10
EP0685232A3 (de) 1996-05-08
JPH07330607A (ja) 1995-12-19
PT685232E (pt) 2000-08-31
NZ272216A (en) 1996-05-28
HU218217B (hu) 2000-06-28
CO4410174A1 (es) 1997-01-09
EP0685232B1 (de) 2000-03-22
PE18796A1 (es) 1996-06-04
GR3033704T3 (en) 2000-10-31
AU694201B2 (en) 1998-07-16
PL308838A1 (en) 1995-12-11
CN1117383A (zh) 1996-02-28
US5776926A (en) 1998-07-07
ES2146265T3 (es) 2000-08-01
NO952138L (no) 1995-12-01
EP0685232A2 (de) 1995-12-06
CZ138595A3 (en) 1996-04-17
DK0685232T3 (da) 2000-08-21
HUT74421A (en) 1996-12-30
DE59508024D1 (de) 2000-04-27
TW301610B (fi) 1997-04-01

Similar Documents

Publication Publication Date Title
IT1267391B1 (it) Procedimento per l'assemblaggio di una batteria bipolare piombo-acido e batteria bipolare ottenuta con tale procedimento.
HK1089387A1 (en) Estrogenic compounds as antimitotic agents
TW349849B (en) Xanthan gelling agents
DE3853191D1 (de) Arzneimittelträger.
CA2151967A1 (en) Magnetic nanocomposite compositions and processes for the preparation and use thereof
FI952629A (fi) Kefiksiimivalmiste
USD304057S (en) Exercise rod
USD266142S (en) Suspension arm for supporting a load such as a wire or cable
USD290729S (en) Inflatable club
DE3875199D1 (de) Dispergiermittel und dieses enthaltende feststoffsuspension.
USD280401S (en) Terminal pin
DE3676256D1 (de) 3',4'-dideoxy-3'-fluorkanamycin b und dessen herstellung.
NO934363L (no) Flegmatisert eksplosiv
ZA88655B (en) 14,15-substituted lanosterols and their use as hypocholesterolemic agents
USD282496S (en) Resuscitator for newborn pigs
USD282495S (en) Bellows unit for aspirator or resuscitator for newborn animals
DE69820098D1 (de) Diamantpartikel, bestehend aus einem diamantenem kern und einem diamantenem überzug
AU3322589A (en) Lubricant
EP0118297A3 (en) Improved blowhead apparatus
GR3035820T3 (en) Hydrate for medicinal use
RU96115480A (ru) Лекарственное средство, обладающее холелитолитическим действием
AU9541898A (en) Azines containing the 5,6-di-hydro-(1,4,2) dioxazine-3-yl group and the use thereof as fungicides
Sanderson The insuring intent of the comprehensive general liability policy
Wrightson The responsive college: rhetoric and reality
AU6438586A (en) 5-naphthyl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants